Federated Hermes’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$590K Buy
2024
Q3
Sell
2024
Q2
$706K Buy
2024
Q1
$163K Buy
2023
Q4
$640 Sell
2023
Q3
$714 Buy
2022
Q2
Sell
2022
Q1
$559K Buy
2021
Q4
$706K Buy
2020
Q3
Sell
2020
Q2
$1K Sell
2020
Q1
$1K Buy